Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biogen Inc (BIIB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 65,521,296
  • Shares Outstanding, K 201,480
  • Annual Sales, $ 12,274 M
  • Annual Income, $ 2,539 M
  • 36-Month Beta 1.01
  • Price/Sales 5.35
  • Price/Cash Flow 12.04
  • Price/Book 4.77

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 6.72
  • Number of Estimates 26
  • High Estimate 7.65
  • Low Estimate 5.96
  • Prior Year 5.26
  • Growth Rate Est. (year over year) +27.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
288.34 +10.60%
on 10/25/18
342.27 -6.83%
on 10/17/18
-12.04 (-3.64%)
since 10/12/18
3-Month
288.34 +10.60%
on 10/25/18
358.41 -11.02%
on 10/01/18
-24.10 (-7.03%)
since 08/10/18
52-Week
249.17 +27.98%
on 04/24/18
388.67 -17.95%
on 07/25/18
+8.46 (+2.73%)
since 11/10/17

Most Recent Stories

More News
Biogen Inc Set to Possibly Rebound After Yesterday's Selloff of 1.54%

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $320.19 to a high of $325.00. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $322.09...

BIIB : 318.90 (-1.94%)
PDL BioPharma (PDLI) Q3 Earnings Top, Revenues Rise, Stock Up

PDL BioPharma's (PDLI) earnings trump estimates in Q3. Higher royalties and product sales aid a significant surge in year-over-year revenues.

PDLI : 2.84 (-0.70%)
GILD : 70.49 (-0.97%)
ALXN : 118.60 (-3.92%)
BIIB : 318.90 (-1.94%)
Watch for Biogen Inc to Potentially Pullback After Gaining 2.35% Yesterday

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $322.40 to a high of $328.42. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $322.42...

BIIB : 318.90 (-1.94%)
5 Top Stocks to Make the Most of a Divided Congress

Gridlock in Washington bodes well for healthcare and defense stocks, which calls for investing in such a space for the time being.

LMT : 305.12 (-2.55%)
JNJ : 145.62 (+0.19%)
MOH : 132.91 (-0.93%)
HCA : 141.91 (-1.42%)
AMGN : 191.56 (-0.83%)
BA : 357.03 (-3.33%)
BIIB : 318.90 (-1.94%)
Election Day 2018: Here Are the Winners & Losers

One of the most awaited midterm elections in American history is upon us. Let's thus look at the sectors most likely to be impacted by the election results.

WFC : 52.35 (-1.30%)
TWTR : 32.01 (-6.07%)
JNJ : 145.62 (+0.19%)
MOH : 132.91 (-0.93%)
HCA : 141.91 (-1.42%)
FB : 141.55 (-2.35%)
AMGN : 191.56 (-0.83%)
BIIB : 318.90 (-1.94%)
Biotech ETFs in Focus on String of Q3 Earnings Beat

Biotech ETFs draw attention post impressive Q3 results.

IBB : 104.45 (-3.04%)
BBH : 119.57 (-2.76%)
FBT : 132.89 (-3.69%)
GILD : 70.49 (-0.97%)
AMGN : 191.56 (-0.83%)
ALXN : 118.60 (-3.92%)
BIIB : 318.90 (-1.94%)
Biogen Inc Rises 3.03% on Heavy Volume: Watch For Potential Pullback

Biogen Inc (NASDAQ:BIIB) traded in a range yesterday that spanned from a low of $304.27 to a high of $314.77. Yesterday, the shares gained 3.0%, which took the trading range above the 3-day high of $310.67...

BIIB : 318.90 (-1.94%)
Biotech ETFs in Focus on String of Q3 Earnings Beat

Biotech ETFs draw attention post impressive Q3 results.

IBB : 104.45 (-3.04%)
BBH : 119.57 (-2.76%)
FBT : 132.89 (-3.69%)
GILD : 70.49 (-0.97%)
AMGN : 191.56 (-0.83%)
ALXN : 118.60 (-3.92%)
BIIB : 318.90 (-1.94%)
What's in the Cards for AbbVie (ABBV) This Earnings Season?

Impressive sales of AbbVie's (ABBV) key drugs, Humira, Imbruvica and Mavyret are expected to drive third-quarter sales.

ALNY : 67.92 (-6.20%)
ABBV : 89.69 (+1.01%)
REGN : 346.56 (-2.83%)
BIIB : 318.90 (-1.94%)
New Research Coverage Highlights Rite Aid, The Boeing, Cabot, Biogen, McDonald's, and Pegasystems -- Consolidated Revenues, Company Growth, and Expectations for 2018

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Rite Aid Corporation (NYSE:RAD),...

RAD : 1.30 (+0.78%)
CBT : 48.45 (-3.10%)
PEGA : 51.05 (-4.63%)
BA : 357.03 (-3.33%)
BIIB : 318.90 (-1.94%)
MCD : 184.37 (-0.84%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade BIIB with:

Business Summary

Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia,...

See More

Key Turning Points

2nd Resistance Point 327.93
1st Resistance Point 323.41
Last Price 318.90
1st Support Level 315.97
2nd Support Level 313.05

See More

52-Week High 388.67
Fibonacci 61.8% 335.38
Fibonacci 50% 318.92
Last Price 318.90
Fibonacci 38.2% 302.46
52-Week Low 249.17

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar